Development of Heat Shock Protein 90-Targeted PDT for Inflammatory Breast Cancer

Download Whitepaper

Development of Heat Shock Protein 90-Targeted PDT for Inflammatory Breast Cancer

Download Whitepaper
In photodynamic therapy (PDT), systemically administered photosensitizer is activated within the tumor using focused near-infrared light, typically a laser with a wavelength matching the absorption peak of the photosensitizer. Several photosensitizers have been clinically approved for the treatment of different cancers; however, their accumulation is non-tumor exclusive which exposes healthy tissues to side effects like daylight-induced phototoxicity. A promising strategy to improve tumor selectivity is to couple photosensitizer to a tumor-targeting agent that binds to a specific antigen expressed on the surface of tumor cells.

Download Whitepaper Now